Optiver Holding’s Johnson & Johnson JNJ Stock Holding History

Optiver Holding’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,013	Closed	-$248K	–	2938
2026 Q1	$248K	Buy	+1,013	New	+$236K	﹤0.01%	771
2025 Q2	–	Sell	-832	Closed	-$138K	–	1546
2025 Q1	$138K	Buy	+832	New	+$130K	﹤0.01%	430
2024 Q3	–	Sell	-2,980	Closed	-$436K	–	1024
2024 Q2	$436K	Buy	+2,980	New	+$443K	﹤0.01%	470

Other funds holding JNJ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Optiver Holding's JNJ Position: Q2 2026 in Review

Optiver Holding sold out of Johnson & Johnson (JNJ) in Q2 2026, closing a stake of 1,013 shares — an estimated $248K sold.

Optiver Holding first reported a position in JNJ in Q2 2024 and held it in 3 quarters. The position peaked at $436K in Q2 2024. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

Optiver Holding reported no remaining Johnson & Johnson position as of Q2 2026 after selling out during the quarter.
Optiver Holding sold 1,013 Johnson & Johnson shares in Q2 2026, an estimated $248K.
Optiver Holding first reported a position in Johnson & Johnson in Q2 2024 and held it in 3 quarters.
Optiver Holding's Johnson & Johnson position peaked at $436K in Q2 2024.
4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.